193 related articles for article (PubMed ID: 29854824)
1. Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.
Guillén-Gómez E; Bardají-de-Quixano B; Ferrer S; Brotons C; Knepper MA; Carrascal M; Abian J; Mas JM; Calero F; Ballarín JA; Fernández-Llama P
J Diabetes Res; 2018; 2018():6165303. PubMed ID: 29854824
[TBL] [Abstract][Full Text] [Related]
2. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
3. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
4. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
5. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients.
Jin J; Ku YH; Kim Y; Kim Y; Kim K; Lee JY; Cho YM; Lee HK; Park KS; Kim Y
Exp Diabetes Res; 2012; 2012():168602. PubMed ID: 22536212
[TBL] [Abstract][Full Text] [Related]
6. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
7. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
8. Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.
Gutta S; Grobe N; Kumbaji M; Osman H; Saklayen M; Li G; Elased KM
Am J Physiol Renal Physiol; 2018 Aug; 315(2):F263-F274. PubMed ID: 29561187
[TBL] [Abstract][Full Text] [Related]
9. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
10. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
Li Q; Feng L; Li J; Chen Q
Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
[TBL] [Abstract][Full Text] [Related]
11. Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.
Alkhalaf A; Zürbig P; Bakker SJ; Bilo HJ; Cerna M; Fischer C; Fuchs S; Janssen B; Medek K; Mischak H; Roob JM; Rossing K; Rossing P; Rychlík I; Sourij H; Tiran B; Winklhofer-Roob BM; Navis GJ;
PLoS One; 2010 Oct; 5(10):e13421. PubMed ID: 20975990
[TBL] [Abstract][Full Text] [Related]
12. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
Currie GE; von Scholten BJ; Mary S; Flores Guerrero JL; Lindhardt M; Reinhard H; Jacobsen PK; Mullen W; Parving HH; Mischak H; Rossing P; Delles C
Cardiovasc Diabetol; 2018 Apr; 17(1):50. PubMed ID: 29625564
[TBL] [Abstract][Full Text] [Related]
13. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
14. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
[TBL] [Abstract][Full Text] [Related]
15. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
16. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
17. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
[TBL] [Abstract][Full Text] [Related]
18. Urinary proteomics for early diagnosis in diabetic nephropathy.
Zürbig P; Jerums G; Hovind P; Macisaac RJ; Mischak H; Nielsen SE; Panagiotopoulos S; Persson F; Rossing P
Diabetes; 2012 Dec; 61(12):3304-13. PubMed ID: 22872235
[TBL] [Abstract][Full Text] [Related]
19. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
20. Urinary exosomes and diabetic nephropathy: a proteomic approach.
Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
